Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Number of holders
-
1270
-
Total 13F shares, excl. options
-
236,903,503
-
Shares change
-
-1,004,557
-
Total reported value, excl. options
-
$83,231,226,220
-
Value change
-
-$329,673,784
-
Put/Call ratio
-
86.23%
-
Number of buys
-
600
-
Number of sells
-
-543
-
Price
-
$351.91
Significant Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q2 2023
1,381 filings reported holding VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock as of Q2 2023.
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) has 1,270 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 236,903,503 shares
of 256,606,920 outstanding shares and own 92.32% of the company stock.
Largest 10 shareholders include BlackRock Inc. (22,820,426 shares), VANGUARD GROUP INC (21,895,959 shares), Capital World Investors (17,340,634 shares), FMR LLC (14,628,666 shares), STATE STREET CORP (12,331,593 shares), WELLINGTON MANAGEMENT GROUP LLP (7,552,894 shares), ALLIANCEBERNSTEIN L.P. (7,535,034 shares), PRICE T ROWE ASSOCIATES INC /MD/ (6,758,758 shares), JPMORGAN CHASE & CO (5,955,525 shares), and GEODE CAPITAL MANAGEMENT, LLC (5,544,861 shares).
This table shows the top 1270 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.